Diferencia entre revisiones de «ACLS (main)»
m (Danbot moved page ACLS (Main) to ACLS (main): Naming convention: first word capitalized, subsequent words lowercase) |
(Add verified PubMed references (PMIDs 34014872, 17125434)) |
||
| Línea 1: | Línea 1: | ||
''See [[critical care quick reference]] for drug doses and equipment size by weight.'' {{AdultPage|PALS (Main)}}. | ''See [[critical care quick reference]] for drug doses and equipment size by weight.'' {{AdultPage|PALS (Main)}}. | ||
==Background== | ==Background== | ||
*A series of clinical algorithms created by the AHA/ASA used in the treatment of cardiovascular/neurological emergencies. | *A series of clinical algorithms created by the AHA/ASA used in the treatment of cardiovascular/neurological emergencies.<ref>Craig-Brangan KJ, Day MP. AHA update: BLS, ACLS, and PALS. Nursing. 2021 Jun 1;51(6):24-30. PMID 34014872</ref> | ||
*Involves airway management, IV access, and ECG interpretation. | *Involves airway management, IV access, and ECG interpretation. | ||
| Línea 56: | Línea 56: | ||
*[[Alcohol abuse]], [[burns]], CNS disease, debilitated or elderly patient, [[drowning]], [[drugs and toxins]], endocrine disease, history of exposure, homelessness, extensive skin disease, spinal cord disease, [[trauma]] | *[[Alcohol abuse]], [[burns]], CNS disease, debilitated or elderly patient, [[drowning]], [[drugs and toxins]], endocrine disease, history of exposure, homelessness, extensive skin disease, spinal cord disease, [[trauma]] | ||
|| | || | ||
*If severe (temperature <30°C), limit initial shocks for [[V-Fib]] or [[pulseless V-Tach]] to three; initiate active internal rewarming and cardiopulmonary support. Hold further resuscitation medications or shocks until core temperature is >30°C. | *If severe (temperature <30°C), limit initial shocks for [[V-Fib]] or [[pulseless V-Tach]] to three; initiate active internal rewarming and cardiopulmonary support. Hold further resuscitation medications or shocks until core temperature is >30°C. <ref>Dager WE, et al. Pharmacotherapy considerations in advanced cardiac life support. Pharmacotherapy. 2006 Dec;26(12):1703-29. PMID 17125434</ref> | ||
*If moderate (temperature 30-34°C), proceed with resuscitation (space medications at intervals greater than usual), actively rewarm truncal body areas | *If moderate (temperature 30-34°C), proceed with resuscitation (space medications at intervals greater than usual), actively rewarm truncal body areas | ||
|- | |- | ||
Revisión actual - 10:49 22 mar 2026
See critical care quick reference for drug doses and equipment size by weight.
This page is for adult patients. For pediatric patients, see: PALS (Main)
.
Background
- A series of clinical algorithms created by the AHA/ASA used in the treatment of cardiovascular/neurological emergencies.[1]
- Involves airway management, IV access, and ECG interpretation.
ECG Analysis
- What is the atrial and ventricular rate?
- Is the rhythm regular or irregular?
- If irregular, does it follow any repeatable pattern?
- What is the axis?
- ERAD often seen in VT but not SVT
- What is the P wave amplitude, duration, morphology, and synchrony with QRS complex?
- Is the P wave positive in Lead II
- What is the QRS complex amplitude, duration, morphology?
- What is the T wave amplitude, duration, morphology?
- Is the T wave positive in Lead II
- What is the length of PR and QT intervals?
- Is there ST Elevation/Depression or Hyperacute T waves?
- If yes, does it follow any anatomical pattern or is it diffuse?
- Is there anything else abnormal about this ECG?
- Pacemaker Spikes
- Hypertrophy of atrial/ventricles
Algorithms
- Adult Pulseless Arrest
- Pulseless Ventricular Tachycardia/Ventricular Fibrillation
- Pulseless Electrical Activity/Asystole
- Cardiac Arrest In Pregnancy
- Adult Post-Cardiac Arrest Care
- Termination of Resuscitation
- ACLS: Bradycardia (with pulse)
- ACLS: Tachycardia (with pulse)
- Acute coronary syndrome
- Suspected cerebrovascular event
Treatable Conditions
| Condition | Common clinical settings | Corrective actions |
| Acidosis |
|
|
| Cardiac tamponade |
|
|
| Hypothermia |
|
|
| Hypovolemia, hemorrhage, anemia |
| |
| Hypoxia |
|
|
| Hypomagnesemia |
|
|
| Myocardial infarction |
|
|
| Poisoning |
|
|
| Hyperkalemia |
|
|
| Hypokalemia |
|
|
| Pulmonary embolism |
|
|
| Tension pneumothorax |
|
|
See Also
- AHA ACLS Recommendation Changes by Year
- ACLS (Treatable Conditions)
- BLS (Main)
- Critical care quick reference
- Post cardiac arrest
- PALS (Main)
External Links
- 2020 AHA Guidelines
- Numose EMed: The Pulseless Patient
- Numose EMed: ACLS Bradycardia
- Numose EMed: ACLS Narrow Complex Tachycardia
- Numose EMed: ACLS Wide Complex Tachycardia
